DYRK1A activity on HBV transcription regulatory regions. by Florentin Pastor (19852287)

Subjects:

Compensatory effects of DYRK1A or DYRK1B levels in HBV-infected PHHs and dHepaRG cells. by Florentin Pastor (19852287)

Subjects:

Effect of DYRK1B and DYRK1B_KR over-expression on HBV parameters. by Florentin Pastor (19852287)

Subjects:

Comparative effects of AZ191 and DB18 in HBV-infected PHH. by Florentin Pastor (19852287)

Subjects:

Time course analysis of DYRK1A and DYRK1B KD in HBV-infected dHepaRG cells. by Florentin Pastor (19852287)

Subjects:

Chemical inhibitors targeting DYRK1A and DYRK1B reduce HBV RNAs production. by Florentin Pastor (19852287)

Subjects:

DYRK1A interacts with HBV cccDNA. by Florentin Pastor (19852287)

Subjects:

RNA levels of selected CMGC kinases in dHepaRG, PHHs and liver biopsies. by Florentin Pastor (19852287)

Subjects:

Longer polyQ sequences increase the tendency of AR to localize to nuclear puncta in the presence of DHT. by Carlos M. Roggero (11909585)

Subjects:

Longer polyQ sequences increase the tendency of AR-NTD to form gels. by Carlos M. Roggero (11909585)

Subjects:

Effect of single or combined DYRK1A/DYRK1B KD in HBV-infected PHHs. by Florentin Pastor (19852287)

Subjects:

BLB resistance assays for homozygous mutant rice lines L-5.7(-6), L-15.4(+1) and L-31.12(-3). by Phuong Nguyen Duy (11414117)

table_1_Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or... by Emerith M. Hungria (4112002)

“…Anti-ND-O-LID antibodies decreased during and after treatment in both groups, similarly to anti-PGL-I antibodies. …”

<b>Predictors of initial and sustained glycemic and weight response to tirzepatide: a post hoc analysis of SURPASS-4</b> by Ewan R. Pearson (157520)

“…<p dir="ltr">This post hoc analysis assessed sustainability of lowered HbA1c and weight with tirzepatide in people with type 2 diabetes and increased cardiovascular risk. …”

Correlations between volumetric decrease in rACC and average cortisol levels for patients (A) and controls (B) and correlations between volumetric decrease in rACC and the combined CTQ scales for physical and sexual abuse for patients (C) and controls (D). by Michael T. Treadway (371126)

“…<p>Correlations between volumetric decrease in rACC and average cortisol levels for patients (A) and controls (B) and correlations between volumetric decrease in rACC and the combined CTQ scales for physical and sexual abuse for patients (C) and controls (D).…”

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

Tailoring 3D-Printed Electrodes for Enhanced Water Splitting by Raúl A. Márquez (13802932)

“…We fabricate robust and cost-effective electrodes through a sequential three-dimensional (3D) printing and metal deposition procedure. …”

Tailoring 3D-Printed Electrodes for Enhanced Water Splitting by Raúl A. Márquez (13802932)

“…We fabricate robust and cost-effective electrodes through a sequential three-dimensional (3D) printing and metal deposition procedure. …”

Tailoring 3D-Printed Electrodes for Enhanced Water Splitting by Raúl A. Márquez (13802932)

“…We fabricate robust and cost-effective electrodes through a sequential three-dimensional (3D) printing and metal deposition procedure. …”

Forest plot and volcano plot of ROR values (95% CI) for the first 30 high signal intensity AEs of penicillamine versus trientine. by Wenlong Qian (22608053)

Subjects: